# FDA 483 - Huntington Reproductive Center Medical Group - October 29, 2024

Source: https://www.globalkeysolutions.net/records/483/huntington-reproductive-center-medical-group/12919cce-d37a-4a7e-a206-1ecca9544d86

> FDA 483 for Huntington Reproductive Center Medical Group on October 29, 2024. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Huntington Reproductive Center Medical Group
- Inspection Date: 2024-10-29
- Product Type: biologics
- Office Name: Los Angeles District Office
- Summary: An FDA inspection of Huntington Reproductive Center Medical Group in Newport Beach, CA, identified two significant observations concerning their HCT/P operations. The firm failed to properly determine donor eligibility based on screening questionnaires, specifically regarding a donor's travel history. Additionally, personal identifying information, such as dates of birth, was found on accompanying records for anonymous oocyte donors.

## Related Documents

- [483 - 2023-03-28](https://www.globalkeysolutions.net/records/483/huntington-reproductive-center-medical-group/17add128-df50-4b8d-b3e9-532fc71c91dc)

## Related Officers

- [Melsomar R. Ramos](https://www.globalkeysolutions.net/people/melsomar-r-ramos/395e7ddc-ed98-455a-a143-0ee5f46804f4)

Company: https://www.globalkeysolutions.net/companies/huntington-reproductive-center-medical-group/1a33acf8-7b85-46f5-9985-dcb95991a8ca

Office: https://www.globalkeysolutions.net/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b